cg0070,nivolumab
cg oncology,bms,kissei
['nivolumab', 'nivo', 'cg0070', 'bladder']
live from #asco22, dr. roger li ( ) shares preliminary results from phase ib/ii neoadjuvant cg0070 and nivolumab for cisplatin-ineligible muscle-invasive bladder cancer. 
The official account of Moffitt Cancer Center. Our mission: to contribute to the prevention and cure of cancer. For news and stories visit https://t.co/XaP6iv4q19.